Cellectis to Hold Third Quarter Earnings Call on Friday, November 5, 2021 at 8AM EDT
NEW YORK, Oct. 28, 2021 (GLOBE NEWSWIRE) -- Cellectis S.A. (NASDAQ: CLLS – EURONEXT GROWTH: ALCLS) (the “Company”), a gene-editing platform company with clinical-stage immuno-oncology…